Folate and homocysteine phenotypes: Comparative findings using research and clinical laboratory data

Area of Science:

• Biochemistry
• Clinical Chemistry
• Analytical Chemistry

Background:

• A low folate/high homocysteine phenotype is linked to pathologies like spina bifida and cardiovascular disease.
• Current clinical methods for folate and homocysteine (tHcy) assessment lack precision.
• Red blood cell (RBC) folate, a key indicator of folate status, is typically measured as total folate, masking the functional roles of different folate derivatives.

Purpose of the Study:

• To evaluate a novel method using stable isotope dilution liquid chromatography-multiple reaction monitoring/mass spectrometry (LC-MRM/MS).
• To quantify specific RBC folate derivatives: 5-methyltetrahydrofolate (5-CH(3)-THF), tetrahydrofolate (THF), and 5,10-methenyltetrahydrofolate (5,10-methenylTHF).
• To assess the utility of these derivatives in predicting tHcy levels and compare them to routine clinical methods.

Main Methods:

• Quantification of RBC folate derivatives (5-CH(3)-THF, THF, 5,10-methenylTHF) using LC-MRM/MS in pre-menopausal women.
• Assessment of each folate derivative's predictive power for tHcy levels.
• Comparison of LC-MRM/MS results with folate and tHcy measurements from standard clinical laboratory methods.

Main Results:

• LC-MRM/MS demonstrated superior qualitative and quantitative performance compared to routine methods for folate and tHcy.
• RBC 5-CH(3)-THF showed a significant inverse correlation with tHcy (p=0.0003).
• RBC THF and RBC 5,10-methenylTHF exhibited direct correlations with tHcy (p=0.01, 0.04).
• The three folate derivatives collectively explained 42% of the variation in tHcy.

Conclusions:

• Precise measurement of RBC 5-CH(3)-THF is crucial for improving folate/homocysteine phenotyping in patient care.
• LC-MRM/MS offers enhanced accuracy and statistical power for studies on hyperhomocysteinemia and associated diseases.
• This advanced methodology has the potential to elucidate the etiologic mechanisms of complex diseases linked to folate metabolism.